The effect of a probiotic blend on gastrointestinal symptoms in constipated patients: a double blind, randomised, placebo controlled 2-week trial
FDA-Approved Branded GLP-1 Medications: Found Health states that affiliated providers can prescribe a range of branded GLP-1 medications including Wegovy (semaglutide, FDA-approved for chronic weight management), Zepbound (tirzepatide, FDA-approved for chronic weight management), Ozempic (semaglutide, FDA-approved for type 2 diabetes and commonly prescribed off-label for weight management), Mounjaro (tirzepatide, FDA-approved for type 2 diabetes and commonly prescribed off-label for weight management), Saxenda and Victoza (liraglutide), Trulicity (dulaglutide), and Rybelsus (oral semaglutide)
The study found that individuals with a specific "responsive" variation of this gene were 82% more likely to be highly responsive to GLP-1 medications. For these individuals, the medication isn't just suppressing appetite
Tirzepatideas with medications in the GLP-1 familymay also improve cardiovascular outcomes, though data is still preliminary
However, where priority determination is for an identical medicine and indication (or a subset of indication) as the orphan designation, applications for determination/designation can be submitted simultaneously with joint justification for certain eligibility criteria [23, 24]